About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 944 record(s)
Req # ATI2024-033
“I would like to have, for all periods available, for loans related to the CDAP program; 1. The number of loan requests received, per month 2. The number of loans accepted, per month 3. The number of loans refused, per month 4. Total capital loaned, per month.”Organization: Business Development Bank of Canada
April 2024
Nothing to report this month
Organization: St. John's Port Authority
Nothing to report this month
Organization: Toronto Port Authority
Req # ATI2024-027
“I would like to obtain all written documents, including official directives and/or internal memos, or any other document of any nature which mentions and refers to the following subjects: the conditions under which a company and/or a person (natural or legal) must meet to obtain a loan, advance, subsidy or any amount granted by Business Development Bank of Canada and also, the conditions under which a company and/or a person (natural or legal) must meet to obtain a release or release from liability from the advance (including guarantees or personal loan guarantees), the subsidy or any other amount granted by BDC.”Organization: Business Development Bank of Canada
February 2024
Req # A-2023-00069
Policy interpretations related to payments and payment service providers issued since the most recent definition for electronic funds transfers (EFTs) was published in April 2022.Organization: Financial Transactions and Reports Analysis Centre of Canada
February 2024
Req # A-2019-000270
Adverse Drug Reactions (ADRs). Report numbers: 000146129, 000191438, 000335588, 000335771, 000338151, 000345474, 00389283, 000390319, 000593310, E2B_00570261, E2B_00570262, E2B_00570263, E2B_00570264.Organization: Health Canada
February 2024
Req # A-2020-000388
Adverse Drug Reactions (ADRs). Report numbers: E2B_02731350, E2B_02777680, E2B_02810755, E2B_02838946, E2B_02852030, E2B_02856401, E2B_02777244, 000735201, E2B_02869967, E2B_02869987, E2B_02869946, E2B_02871897, E2B_02871900, E2B_02871882, E2B_02871883.Organization: Health Canada
February 2024
Req # A-2020-000647
Adverse Drug Reactions (ADRs) for PANTOPRAZOLE. Report numbers: 000736259, 000738096, 000911912, E2B_02993730, E2B_03001785, E2B_03004317, E2B_03005410, E2B_03015111, E2B_03020794, E2B_03024205, E2B_03034122, E2B_03038830, E2B_03047792. ADRs for PANTOPRAZOLE MAGNESIUM. Report numbers: E2B_03047105, E2B_03003181, E2B_03005697, 000908663. ADR for PANTOPRAZOLE SODIUM. Report number: E2B_03045008. ADR for TECTA. Report number: E2B_03014229.Organization: Health Canada
February 2024
Req # A-2020-000731
Adverse Drug Reactions (ADRs) for Estrogel. Report numbers: 000693076, E2B_002778333. ADR for Ezetrol. Report number: E2B_01181304. ADRs for Fosamax. Report numbers: 000675450, 00685185, E2B_00037382, 000518360, 000555402, 000543195, E2B_00256053, E2B_00066044.Organization: Health Canada
February 2024
Req # A-2020-000800
Adverse Drug Reactions (ADRs) for Fosamax. Report numbers: E2B_00498826, E2B_00498902, E2B_00500827, E2B_00506460, E2B_00786970, E2B_00894613, E2B_00894617, E2B_00894629, E2B_00896465, E2B_00898784, E2B_00898796, E2B_00898918, E2B_00941125, E2B_00944258, E2B_00946463, E2B_00947254, E2B_00786948, E2B_00792724, E2B_01103249, E2B_01104135.Organization: Health Canada
February 2024